Key statistics
On Tuesday, Collegium Pharmaceutical Inc (354:DUS) closed at 34.20, -10.00% below its 52-week high of 38.00, set on Oct 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 35.60 |
---|---|
High | 35.80 |
Low | 34.20 |
Bid | 34.20 |
Offer | 35.00 |
Previous close | 36.20 |
Average volume | 15.00 |
---|---|
Shares outstanding | 32.21m |
Free float | 31.79m |
P/E (TTM) | 17.33 |
Market cap | 1.28bn USD |
EPS (TTM) | 2.30 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 18:30 BST.
More ▼
Announcements
- Collegium Completes Acquisition of Ironshore Therapeutics
- Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference
- Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024
- Collegium Reports Second Quarter 2024 Financial Results
- Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology
- Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024
- Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise
- Collegium to Participate in Jefferies Global Healthcare Conference
- Collegium Announces $35 Million Accelerated Share Repurchase Program
- Collegium Reports First Quarter 2024 Financial Results
More ▼